scholarly article | Q13442814 |
P50 | author | Hashem El-Serag | Q5678908 |
Jennifer Kramer | Q88793726 | ||
Fasiha Kanwal | Q91056301 | ||
Gia L Tyson | Q125207456 | ||
P2093 | author name string | Liang Chen | |
Zhigang Duan | |||
Robert L Kruse | |||
P2860 | cites work | The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases | Q45332145 |
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers | Q45333283 | ||
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. | Q53118691 | ||
Utilization of screening for hepatocellular carcinoma in the United States. | Q53468518 | ||
The prevalence and natural history of hepatitis B in the 21st century | Q83895711 | ||
Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions | Q29036593 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study | Q31102359 | ||
Direct-acting antiviral agents and the path to interferon independence | Q33727347 | ||
Hepatitis B virus X protein interferes with cellular DNA repair. | Q33781959 | ||
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults | Q34387456 | ||
Clinical Case Registries: simultaneous local and national disease registries for population quality management | Q34407096 | ||
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
Occult hepatitis B. | Q34768651 | ||
High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study | Q35950941 | ||
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? | Q36190321 | ||
Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment | Q37132382 | ||
Hepatitis B and C in African Americans: current status and continued challenges | Q37627088 | ||
Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. | Q37709943 | ||
Management of hepatitis C in HIV and/or HBV co-infected patients. | Q38064000 | ||
The performance of process measures in hepatitis C. | Q39589157 | ||
Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population | Q42263840 | ||
Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection | Q42285091 | ||
Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration | Q42734408 | ||
Hepatitis-B virus infection predicts mortality of HIV and hepatitis C virus coinfected patients | Q42988871 | ||
Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. | Q42989324 | ||
Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection | Q42994086 | ||
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients | Q42996981 | ||
Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference | Q43033375 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | United States of America | Q30 |
Hepatitis B virus | Q6844 | ||
hepatitis B | Q6853 | ||
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 1871-1878 | |
P577 | publication date | 2014-10-29 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients | |
P478 | volume | 60 |
Q101469848 | Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection |
Q27010130 | Evolving roles of circadian rhythms in liver homeostasis and pathology |
Q40413383 | HBV/HCV co-infection is associated with a high level of HCV spontaneous clearance among drug users and blood donors in China. |
Q89899473 | Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy |
Q64126919 | Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients |
Q33874864 | Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study. |
Q91801771 | Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection |
Q54243868 | Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review. |
Q94453487 | Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment |
Q40584139 | Hospitalizations in Immigrants and Nonimmigrants Diagnosed With Chronic Hepatitis C Infection in Québec. |
Q36937018 | Is exposure to Agent Orange a risk factor for hepatocellular cancer?-A single-center retrospective study in the U.S. veteran population |
Q39758401 | Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability. |
Q40823860 | Mediation effect of hepatitis B and C on mortality. |
Q50934392 | Natural History of Hepatitis C. |
Q37411514 | Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection |
Q51761924 | Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. |
Q85504135 | Recent Publications by Ochsner Authors |
Q33851416 | Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis |
Q42334045 | Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C. |
Q36951915 | Veterans Affairs Office of Research and Development: Research Programs and Emerging Opportunities in Digestive Diseases Research |
Search more.